Transaction overview

Nuveen, a subsidiary of TIAA in the United States, acquired 100% equity stake in Schroders, a British asset management firm founded in 1804. The deal was valued at $12.9 billion and was announced on February 17, 2026, though the exact close date has not been disclosed yet. This acquisition is aimed at creating one of the world’s largest active asset managers with combined assets under management of nearly £1.8 trillion across institutional and wealth channels.

Deal structure and financing

The deal's financial details are currently undisclosed, including specifics about equity/debt split or any retained stake by Schroders. The lead banks involved in the transaction have not been revealed either. However, it is known that shareholders will receive 612 pence per share, reflecting a value of £9.9 billion for Schroders' total enterprise. While lock-up terms and IPO optionality are yet to be clarified, this strategic move signifies an attempt by both companies to consolidate their global presence in the asset management sector.

Strategic context

Nuveen's acquisition of Schroders is primarily driven by its ambition to expand globally while enhancing its active asset management capabilities. This deal allows Nuveen to gain access to Schroders' wealth management client base and distribution networks across EMEA and Asia-Pacific regions, complementing its existing US footprint. On the other hand, Schroders seeks a strategic partner that can provide significant growth opportunities in both public and private markets. The rationale for divestiture is rooted in the desire to leverage Nuveen’s extensive resources and global reach without diluting the value of Schroders’ brand and legacy as an independent asset manager.

Regulatory path

Both companies have not disclosed specific details regarding regulatory reviews or potential remedies required by authorities. However, given the deal's substantial size and cross-border nature involving US and UK entities, it is likely that antitrust scrutiny will be conducted by relevant bodies such as the Federal Trade Commission (FTC) in the United States and the Competition and Markets Authority (CMA) in the United Kingdom. Additionally, the transaction would have necessitated filings under the Hart-Scott-Rodino Antitrust Improvements Act (HSR) for US regulatory review prior to completion.